Home Ecommerce Gum And Mints Brand Neuro Isn’t Letting Coronavirus Chew Up Its Marketing Plans

Gum And Mints Brand Neuro Isn’t Letting Coronavirus Chew Up Its Marketing Plans

SHARE:

After Neuro, which manufactures natural caffeine-infused gum and mints, rebranded in February, it was gearing up to double down on retail, including at CVS pharmacies, GNC stores and Barnes & Noble locations on college campuses.

Best-laid plans. COVID-19 hit the United States hard in early March.

But co-founders Ryan Chen and Kent Yoshimura, who met as undergrads at UC San Diego and have degrees in chemistry and neuroscience respectively, are chill dudes from LA, and they’re rolling with the situation.

“With unemployment the way it is and the economy faltering, consumers are looking for essentials,” said Yoshimura, who started the company with Chen in 2015. “We’re hoping people think of an energy product as essential, but the reality is we know there are more important things than us out there right now.”

Gum is often an impulse buy at checkout, rather than part of a larger online order, which is translating to softer sales in the category as people shelter at home. During its Q1 earnings call, for example, Mondelēz said its gum brands were “severely impacted” due to the ongoing pandemic.

Neuro is somewhat insulated from these challenges, in part because it’s a specialty product, and because most of its sales today still come from ecommerce, despite its retail aspirations.

Amazon sales have been steady during lockdown, Yoshimura said.

Even so, physical events are a linchpin of Neuro’s marketing. The brand has seen particular success handing out samples at CrossFit events and partnering with CrossFit influencers. Neuro sponsors two of the top female CrossFit athletes in the United States.

Spreading awareness IRL is on hold for the duration, of course, Chen said. But there are other things Neuro can do to stay top of mind with consumers. Neuro is partnering, for example, with fitness professionals to create exercise content and diet plans for people stuck at home.

“It’s an opportunity to provide content that could be helpful rather than something that’s purely marketing,” Yoshimura said.

Neuro is also giving away free products to frontline hospital workers and EMTs who message its support email.

Subscribe

AdExchanger Daily

Get our editors’ roundup delivered to your inbox every weekday.

“It’s a small way we can help, because the place they usually buy their energy drinks might be closed,” Yoshimura said. “We’re just trying to figure this out day by day and working with our marketing team to take advantage of media opportunities to bring us more awareness.”

The single biggest media opportunity Neuro snagged recently was a spot on “Shark Tank.” The episode, which aired April 10 on ABC, was in the can long before COVID-19 existed, but was broadcast into a world under quarantine. Last year, “Shark Tank” had started to drop in the ratings. The April 10 episode drew nearly 5 million viewers.

Although Chen and Yoshimura didn’t end up doing a deal, within 24 hours of their appearance on the show, Neuro did six figures in sales.

“It was a very big deal for us,” Yoshimura said. “Although I have to say that one of the main things I remember from filming is … how much makeup they put on our faces.”

Must Read

Netflix Boasts Its Best Ad Sales Quarter Ever (Again)

In a livestreamed presentation to investors on Tuesday, co-CEO Greg Peters shared that Netflix had its “best ad sales quarter ever” in Q3, and more than doubled its upfront commitments for this year.

Comic: No One To Play With

Google Pulls The Plug On Topics, PAAPI And Other Major Privacy Sandbox APIs (As The CMA Says ‘Cheerio’)

Google’s aborted cookie crackdown ends with a quiet CMA sign-off and a sweeping phaseout of Privacy Sandbox technologies, from the Topics API to PAAPI.

The Trade Desk’s Auction Evolutions Bring High Drama To The Prebid Summit

TTD shared new details about OpenAds features that let publishers see for themselves whether it’s running a fair auction. But tension between TTD and Prebid hung over the event.

Privacy! Commerce! Connected TV! Read all about it. Subscribe to AdExchanger Newsletters
Monopoly Man looks on at the DOJ vs. Google ad tech antitrust trial (comic).

How Google Stands In The DOJ’s Ad Tech Antitrust Suit, According To Those Who Tracked The Trial

The remedies phase of the Google antitrust trial concluded last week. And after 11 days in the courtroom, there is a clearer sense of where Judge Leonie Brinkema is focused on, and how that might influence what remedies she put in place.

The Ad Context Protocol Aims To Make Sense Of Agentic Ad Demand

The AI advertising agents will need their own trade group eventually. For now though, a bunch of companies are forming the Ad Context Protocol, or AdCP.

OUTFRONT Is Using Agencies’ AI Enthusiasm To Spur Wider Programmatic OOH Adoption

The desire for a data-driven reinvention of OOH inspired OUTFRONT to create agentic AI tools for executing and measuring OOH campaigns and comparing OOH to other channels.